DiaCarta raises $8 mln

DiaCarta said Friday it raised $8 million in Series A financing from BVCF (BioVeda China Fund). Hayward, Calif.-based DiaCarta is a molecular diagnostics company.

9 January 2015•2 mins read
Feature image
LinkedInXEmail
LinkedInXEmail